We use our proprietary mass spectrometry workflow, computational biology, and information technology capabilities to provide our partners with comprehensive proteomic and epiproteomic profiling tools.
We collaborate with academic and pharmaceutical partners to elucidate new molecular pathways leading to disease, by combining high resolution mass spectrometry, glycobiology insights, multi-omic analyses and bioinformatics.
We support drug development and clinical trial success by providing epiproteomic and glycoproteomic profiling tools to pharmaceutical companies. We provide analyses of retrospectively and prospectively collected serum / plasma samples to enable patient stratification and selection, efficacy and treatment monitoring, and development of companion diagnostics.
Please fill out the form below or email us at firstname.lastname@example.org